Cargando…
The phenotypic expression of mitochondrial tRNA-mutations can be modulated by either mitochondrial leucyl-tRNA synthetase or the C-terminal domain thereof
Mutations in mitochondrial (mt) DNA determine important human diseases. The majority of the known pathogenic mutations are located in transfer RNA (tRNA) genes and are responsible for a wide range of currently untreatable disorders. Experimental evidence both in yeast and in human cells has shown th...
Autores principales: | Giordano, Carla, Morea, Veronica, Perli, Elena, d’Amati, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370040/ https://www.ncbi.nlm.nih.gov/pubmed/25852750 http://dx.doi.org/10.3389/fgene.2015.00113 |
Ejemplares similares
-
Short peptides from leucyl-tRNA synthetase rescue disease-causing mitochondrial tRNA point mutations
por: Perli, Elena, et al.
Publicado: (2016) -
The isolated carboxy-terminal domain of human mitochondrial leucyl-tRNA synthetase rescues the pathological phenotype of mitochondrial tRNA mutations in human cells
por: Perli, Elena, et al.
Publicado: (2014) -
Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations
por: Hornig-Do, Hue Tran, et al.
Publicado: (2014) -
A Leucyl-tRNA Synthetase Urzyme: Authenticity of tRNA Synthetase Catalytic Activities and Promiscuous Phosphorylation of Leucyl-5′AMP
por: Hobson, Jessica J., et al.
Publicado: (2022) -
A human leucyl-tRNA synthetase as an anticancer target
por: Gao, Guangwei, et al.
Publicado: (2015)